Fifteen years in oncology. One new chapter.
The Milestone
This year marks 15 years of Cetas Healthcare supporting clients across oncology — from cancer screening and diagnostics, to imaging, to the broader decisions that shape oncology innovation.
The Shift
Over that time, the ground has shifted. Oncology decision-making has become more interconnected than ever. Diagnostics, imaging, and therapeutics no longer sit in separate silos — they converge on the same patient, the same pathway, the same decision.
We built Oncospective to meet that shift head-on.
From IVD to therapeutics
Oncospective is a dedicated oncology insights practice, built on Cetas' established expertise across IVD, devices, and imaging — and extended further into therapeutics. It's the natural next step for a practice that has spent 15 years watching oncology's disciplines move closer together, and building the capability to serve all of them at once.
Oncospective is the oncology insights practice of Cetas Healthcare — 15 years of MedTech, diagnostics, and imaging expertise, now extended into therapeutics.
What makes us different
Most research partners specialize in one part of the oncology pathway. We're built to work across all of them — because that's how oncology decisions actually get made now. It's oncology expertise with the reach of a global partner and the attention of a dedicated practice.
Terri Crudup
Oncospective is led by Terri Crudup.
Terri brings more than 20 years of primary market research insights experience — and the perspective of a two-time cancer survivor and outspoken patient advocate — to clients navigating an increasingly connected oncology landscape.
Years of oncology insight
Deep industry expertise combined with lived patient perspective.